constipation%20in%20adults%20-%20chronic%20functional
CONSTIPATION IN ADULTS - CHRONIC FUNCTIONAL
Constipation is an unsatisfactory defecation distinguished by difficult stool passage, infrequent stools or both.
Difficult stool passage may include straining, feeling of difficulty in passing stool, incomplete evacuation, lumpy/hard stools, prolonged time to defecate, need for manual maneuver to pass stool, abdominal discomfort and feeling of anorectal blockade.
Chronic constipation is considered when symptoms of constipation have existed ≥3 months.
Symptoms of chronic constipation may be due to dysfunction of intestinal motility, visceral sensitivity, anorectal musculature or the enteric nervous system.

Patient Education

  • Engage in regular exercise
  • Inform patient that therapy is comprehensive in order to restore the defecation physiology
  • Reassure and explain about normal bowel habits
    • Encourage patients to defecate when colonic activity is highest (eg upon waking, after meals)

Lifestyle Modification

Dietary Modification

  • Patients should be advised to gradually increase their soluble dietary fiber
    • If possible, dietary fiber via fruits, vegetables and whole grains should be increased to 20-30 g/day
    • If this is not effective, commercial fiber supplements (bulk-producing laxatives) may be added, avoid if bloating is present
  • Patients may be encouraged to maintain adequate hydration (2-2.5 L/day), though increased fluid intake does not appear to relieve chronic constipation except in those who are dehydrated
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
18 Sep 2019
Mortality, length of stay (LOS) and hospital charges are significantly higher in chronic liver disease (CLD) patients with fractures, a recent study has shown. These findings are also associated with increased infection, bleeding and poorer wound healing.
01 Aug 2017
New drug applications approved by US FDA as of 16 - 30 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
07 Jun 2019
Gastro-oesophageal reflux disease (GERD) is common among obese patients qualified for bariatric surgery, underscoring the need for preoperative endoscopic assessment, a recent study has shown.
22 Sep 2019
Oral supplementation with the gut commensal bacterium Akkermansia muciniphila safely improves several metabolic parameters in overweight or obese adults, as shown in a proof-of-concept study.